Диссертация (1145006), страница 45
Текст из файла (страница 45)
Engl. J. Med. 2000. - Vol. 343. - P. 1139 - 1147.238. Maugeri, N. An intense and short-lasting burst of neutrophil activationdifferentiates early acute myocardial infarction from systemic inflammatorysyndromes /N. Maugeri, P. Rovere-Querini, V. Evangelista V. [et al.] //PLoS One. –2012. – Vol.7, № 6. – Р. 39484.239. McIlroy, D.R. Neutrophil Gelatinase-Associated Lipocalin and Acute KidneyInjury after Cardiac Surgery: The Effect of Baseline Renal Function on DiagnosticPerformance /D.R. McIlroy, G. Wagener, H.T. Lee //Clin.
J. Am. Soc. Nephrol. 2010. - Vol. 5. - P. 211 - 219.240. МcCullough,P.A. Contrast – induced nephropathy /P.A. МcCullough, S.S.Soman //Crit. Care Clin. – 2005. – Vol. 21. – P. 261-280.241. Mehran, R. Contrast-induced nephropathy: Definition, epidemiology, and patientat risk /R. Mehran, E. Nikolsky E //Kidney Int., Suppl. - 2006, Apr. – Vol. 100. S11-S15.242. Meisinger, C.
KORA Study Group. Chronic kidney disease and risk of incidentmyocardial infarction and all-cause and cardiovascular disease mortality in middleaged men and women from the general population /C. Meisinger, A. Doring , H.Lowel //Eur. Heart J. - 2006. - Vol. 27, №10. - P. 1245 – 1250.243. Mitra, A.K. In stent restenosis bane of the stent era /A.К. Mitra, D.K. Agrawal//J. Clin. Pathol. – 2006. - Vol. 59. - P. 232 – 239.244.
Modi, K.S. Atheroembolic renal disease /K.S. Modi , V.K. Rao //J. Am. Soc.Nephrol. – 2001. - Vol. 12. - P. 1781 – 1787.277245. Morcos, S.K. Contrast-media-induced nephrotoxicity: a consensus report.Contrast Media Safety Committee, European Society ofUrogenital Radiology(ESUR) /S.K. Morcos, H.S. Thomsen, J.A. Webb //Eur. Radiol.
–– 1999. – Vol. 9. –P. 1602 –1613.246. Mortality benefit of immediate revascularization of acute ST – segment elevationmyocardial infarction in patients with contraindications to thrombolytic therapy /M.Grzybow ski, E.A. Clements, I. Parsons [et al.] //JAMA. - 2003. – Vol. 290. – P.1891 - 1898.247. Moss, N.G. Neural control of renal function. Handbook of Physiology, RenalPhysiology /N.G.Moss, R.E. Colinders, C.W.Gottschalk.
-NY: OxfordUniversity Press, 1992. – P. 1061-1127.248. Murugan, R. Acute kidney injury: what is the prognosis? /R. Murugan, J.A.Kellum// Nat. Rev. Nephrol. - 2011. - Vol. 7. - P. 209 – 217.249.National Kidney Foundation. KDOQI Clinical Practice Guidelines and ClinicalPractice Recommendations for Diabetes and Chronic Kidney Disease //Am. J.Kidney Dis. - 2007. – Vol. 49, Suppl. 2. – S.
12 - 154.250. Natriuretic peptides in coronary disease with non ST elevation: new tools readyfor clinical application /A. Palazzuoli, G. Giannotti, F. Iovine [et al.] //Recent Pat.Cardiovasc. Drug. Discov. – 2007. – Vol. 2, № 1. – P. 14.251. NEFROINT invesnigators. Prospective multictnter study on epidemiology ofacute kidney injury in the ICU: a critical care nephrology Italian collaborative effort(NEFROINT) /P. Piccinni, D.N.
Cruz, S. Gramaticopolo //Minerva Anestesiol. –2011. - Vol. 77. - P. 1072 - 1083.252. Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidneyinjury: a review of the laboratory characteristics and clinical evidences /A. Clerico,C. Galli, A. Fortunato [et al.] //Clin. Chem. Lab. Med. - 2012 Feb. 15. - Vol. 50, №9. - P. 1505 - 1517.253. Next-generation biomarkers for detecting kidney toxicity /J.V.
Bonventre, V.S.Vaidya, R. Schmouder [et al.] //Nat. Biotechnol. - 2010. - Vol. 28. - P. 436 - 440.278254. Nikolsky, E. Understending the consequences of contrast-induced nephropathy/E. Nikolsky, R. Mehran //Rev. Cardiovasc. Med. - 2003. - Vol. 4, Suppl. 5. - S10S18.255. Nishikimi, T. The role of natriuretic peptides in cardioprotection /T.
Nishikimi,N. Maeda, H. Matsuoka //Cardiovasc. Res. - 2006. - Vol. 69, №2. - P. 318-328.256. NKF-K/DOKI clinical practice guidelines for chronic kidney diseases:evaluation, classification and stratification //Am. J. Kidney Dis. - 2002. - Vol. 39,Suppl. 1. - S17 - S31.257. Novel biomarkers early predict the severity of acute kidney injury after cardiacsurgery in adults /M. Haase, R. Bellomo, P. Devarajan [et al.] //Ann.
Thorac. Surg.- 2009. - Vol. 88. - 124 - 130.258. N-terminal pro-brain natriuretic peptide and other risk markers for the separateprediction of mortality and subsequent myocardial infarction in patients withunstable coronary artery disease: a Global Utilization of Strategies To Openoccluded arteries (GUSTO)-IV substudy /S.K. James, В. Lindahl, A. Siegbahn, М.Stridsberg [et al.] //Circulation 2003. - Vol. 108. - P. 275 – 281.259.
Outcome of heart failure with preserved ejection fraction in a population-basedstudy /R.S. Bhatia, J.V. Tu , Lee D.S. [et al.] //N. Engl. J. Med. - 2006. - Vol. 355. P. 260 – 269.260. Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome/E. Cavusoglu, J. D. Marmur, M. R. Hojjati [et al.] //Am. J. Med.- 2011. - Vol. 124,№ 8. - P. 724 – 730.261. The pathophysiologic roles of interleikin-6 in human disease /D.A.Papanicolaou, R.L. Wilder, S.C. Manolagos Chrousos G. P. [et al.] //Ann. Intern.Med.- 1998. - Vol. 128. - P. 127 – 137.262. Patel, M.R.
Prognostic usefulness of blood white cell count and temperature inacute myocardial lnfarction (from the CARDINAL trial). /M.R. Patel //J. Am. Coll.Cardiol. - 2005. - Vol. 95. - P. 614 - 618.279263. Prediction of risk of death and myocardial infarction in the six months afterpresentation with acute coronary syndrome: prospective multinational observationalstudy (GRACE) /Fox KA, Dabbous OH, Goldberg RJ [et al.]// B.M.J. - 2006. - Vol.333. - P. 1091.264. Predictive value of C-reactive protein and troponin T in patients with unstableangina: a comparative analysis. CAPTURE Investigators.
Chimeric. Anti PlateletTherapy in Unstable angina RE fractory to standard treatment trial /C. Heeschen,C.W. Hamm, J. Bruemmer [et al.] //J. Am. Coll. Cardiol.- 2000.- Vol. 35. - P. 1535– 1542.265. Predictive value of elevated white cell count in patients with preexistingcoronary heart disease /М. Haim, V. Boyko, U. Goldbourt [et al.] //Arch.
Intern.Med. - 2004. Vol. 164. - P. 433–439.266. Predictive value of NT-pro BNP after acute myocardial infarction: relation withacute and chronic infarct size and myocardial function /A. Mayr, J. Mair, M.Schocke [et al.] //Int. J. Cardiol. – 2011. – Vol. 147, № 1. – P. 118–123.267.
Prevalence and impact of worsening renal function in patients hospitalized withdecompensated heart failure: results of the prospective outcomes study in heartfailure (POSH) /M.R. Cowie, M. Komajda, T. Murray-Thomas [et al.] //Eur. HeartJ. - 2006. - Vol. 27. - P. 1216-1222.268. Prevalence of chronic kidney disease and decreased kidney function in the adultUS population. Third National Health and Nutrition Examination Survey /J. Coresh ,C. B. Astor, T. Greene [et al.] ∕∕Am.
J. Kidney Dis. - 2003. - Vol. 31. - P.1-12.269. Prevalence of low glomerular filtration rate in nondiabetic Americans: ThirdNational Health and Nutrition Examination Survey (NHANES III) //J. Am. Soc.Nephrol. - 2002. - Vol. 13, № 5. - P. 1338 –1349.270. Prevalence, Predictors, and Prognostic Value of Renal Dysfunction in AdultsWith Congenital Heart Disease /K. Dimopoulos, G.P. Diller, E. Koltsida [et al.]//Circulation.- 2008.
- Vol. 117. - P. 2320 – 2328.280271. Primary angioplasty versus fibrinolysis in acute myocardial infarction: long termfollow-up in the Danishacute myocardial infarction 2 trial /P.H. Nielsen, M.Maeng, M. Busk [et al.] //Circulation. - 2010. – Vol. 121, № 13. - P. 1484 -1491.272. Prognostic importance of physical examination for heart failure in non-STelevation acute coronary syndromes: the enduring value of Killip classification/Khot UN, Jia G, Moliterno DJ, [et al.] //JAMA.
- 2003. - Vol. 290. - P. 2174 – 2181.273. Prognostic value of ST segment depression in acute coronary syndromes: insightsfrom PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIbInvestigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute GlobalOrganization Network /P.Kaul, Y.
Fu, W.C. Chang [et al.] //J. Am. Coll. Cardiol. 2001. - Vol. 38. - P. 64 – 71.274. Prognostic value of serum cystatin C and N-terminal pro b-type natriureticpeptide in patients with acute heart failure /J.I. Perez-Calvo, F.J. Ruiz-Ruiz, F.J.Carrasco-Sanchez [et al.] //Eur. J. Intern. Med. - 2012 Oct. - Vol. 23, № 7.
- P. 599–603.275. Prognostic value of transient and sustained increase in in-hospital creatinine onoutcomes of patients admitted with acute coronary syndrome /R. Latchamsetty, J.Fang, E. Kline-Rogers [et al.] //Am. J. Cardiol. - 2007. - Vol. 99, № 7. - P. 939-942.276. Prostaglandin E2 Promotes Integrin α3Vβ3-dependent Endothelial Cell Adhesion,Rac-activation and Spearing through cAMP/PKA – dependent Signalling /O.Dormond, M.
Bezzi, A. Mariotti [et al.] //J. Biol. Chem. – 2002. – Vol. 277. - № 48.– P. 45838 - 45846.277. Protective Roles of Mast Cells Against Enterobacterial Infection are Mediated byToll-like Receptor 4 /V. Supajatura, H. Ushio, A. Nakao [et al.] //The J. ofImmunology. – 2001. – Vol. 167. – P. 2250 - 2256.278. Quantitative analysis of the admission electrocardiogram identifies patients withunstable coronary artery disease who benefit the most from early invasive treatment/L. Holmvang , P. Clemmensen, В.
Lindahl [et al.] //J. Am. Coll. Cardiol.- 2003.Vol. 41. – P. 905 – 915.281279. Rader, D. L. Inflammatory markers of coronary risk /D.L. Rader //N. Engl.J. Med. - 2000. - Vol. 343. - P. 1179–1182.280. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis ofheart failure /A.S. Maisel, P. Rrishnaswamy, R.M. Nowak [et al.] //N. Engl. J.Med. - 2002. - Vol. 347. - P. 161- 167.281. Recommendations for the structure, organization, and operation of intensivecardiac care units /Y.
Hasin, N. Danchin, G.S. Filippatos [et al.] //Eur. Heart. J. –2005. - Vol. – 26. – P. 1676 – 1682.282. Recommendations for the use of natriuretic peptides in acute cardiac care: aposition statement from the Study Group on Biomarkers in Cardiology of the ESCWorking Group on Acute Cardiac Care /К. Thygesen, J. Mair, C. Mueller [et al.]//Eur. Heart. J.- 2012.- Vol. 33, № 16. - P. 2001 - 2006283. Renal insufficiency and mortality from acute coronary syndromes/F.A.Masoudi, М.Е. Plomondon, D.J.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
